Name: Latest research reports of eClerx Services Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: eClerx Services Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	31 Jan 2025	eClerx Services	BOB Capital Markets Ltd.	3784.10	3727.00	3058.15 (23.74%)	Target met	Buy	pdf post cache	Broker Report eClerx Services (BUY): Should be among the faster growing Tier-2 players BOB Capital Markets Ltd. 3QFY25 broadly in line. A margin miss. Expect 4Q QoQ growth to be stronger. Expect low teen USD revenue growth in FY25-FY27. pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Voltas	BOB Capital Markets Ltd. Target	1336.00	1400.00	1260.85 (5.96%)	Target met	Hold	pdf post cache	Broker Report Voltas (HOLD): Revenue in line with estimates, PAT sees lag BOB Capital Markets Ltd. Topline grew 18% YoY in Q3; EBITDA margin expanded 530bps YoY fueled by better cost efficiencies pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Ajanta Pharma	BOB Capital Markets Ltd. Target	2800.50	2288.00	2694.45 (3.94%)	18.30	Sell	pdf post cache	Broker Report Ajanta Pharma (SELL): Entering newer therapies to result in higher costs BOB Capital Markets Ltd. AJP reported in-line earnings, sales were 3.6% below estimates, while EBITDA/PAT reported 1%/3% above our estimates pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Dabur	BOB Capital Markets Ltd. Reco Target	522.00	578.00	529.85 (-1.48%)	10.73	Hold	pdf post cache	Broker Report Dabur India (HOLD): Competition and inflation BOB Capital Markets Ltd. Competitive intensity has increased in the domestic business and Dabur is doing retailer discounts to maintain market share pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Tata Consumer	BOB Capital Markets Ltd. Target	1073.10	1175.00	1024.65 (4.73%)	Target met	Buy	pdf post cache	Broker Report Tata Consumer Products (BUY): Staying rational BOB Capital Markets Ltd. Tea inflation recovery prospects have improved as higher pricing has come through earlier than expected pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	IDFC First Bank	BOB Capital Markets Ltd. Target	69.24	75.00	56.73 (22.05%)	Target met	Buy	pdf post cache	Broker Report IDFC First Bank (BUY): Subdued performance, elevated provisioning BOB Capital Markets Ltd. Earnings lower on account of higher slippages, moderate loan book growth pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	ICICI Bank	BOB Capital Markets Ltd. Reco Target	1482.40	1415.00	1227.95 (20.72%)	Target met	Buy	pdf post cache	Broker Report ICICI Bank (BUY): Continue to demonstrate stable performance BOB Capital Markets Ltd. PAT growth of 15% YoY aided by stable credit cost and PPOP growth of 15% YoY pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	Laurus Labs	BOB Capital Markets Ltd. Target	881.45	488.00	534.65 (64.86%)	44.64	Sell	pdf post cache	Broker Report Laurus Labs (SELL): Margin guidance shifted from 20% to closer to 20% for FY25E BOB Capital Markets Ltd. Revenue/EBITDA/PAT exceeded our estimates by 10.5%/46.6%/227%. EBITDA margin surpassed our estimate by 500bps pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	DCB Bank	BOB Capital Markets Ltd. Target	141.94	140.00	117.79 (20.50%)	Target met	Buy	pdf post cache	Broker Report DCB Bank (BUY): Solid performance BOB Capital Markets Ltd. Robust business growth with strong advances growth above our estimates pdf Copy Link Share on Share on Share on Share on Alert
	25 Jan 2025	MphasiS	BOB Capital Markets Ltd. Reco Target	2806.60	2651.00	3009.30 (-6.74%)	Target met	Sell	pdf post cache	Broker Report Mphasis (SELL): Not a steady performing Tier-2 player yet BOB Capital Markets Ltd. 3QFY25 has yet again proven the volatility in Mphasis's business compared to its Tier-2 peers like Persistent & Coforge pdf Copy Link Share on Share on Share on Share on Alert
more loading

BOB Capital Markets Ltd. Broker Research reports

Latest broker research reports from BOB Capital Markets Ltd. buy, sell, hold, neutral recommendations along with share price targets forecast and upside.

eClerx Services (BUY): Should be among the faster growing Tier-2 players

Voltas (HOLD): Revenue in line with estimates, PAT sees lag

Ajanta Pharma (SELL): Entering newer therapies to result in higher costs

Dabur India (HOLD): Competition and inflation

Tata Consumer Products (BUY): Staying rational

IDFC First Bank (BUY): Subdued performance, elevated provisioning

ICICI Bank (BUY): Continue to demonstrate stable performance

Laurus Labs (SELL): Margin guidance shifted from 20% to closer to 20% for FY25E

DCB Bank (BUY): Solid performance

Mphasis (SELL): Not a steady performing Tier-2 player yet

Advisor Screeners